Efficacy, Safety and Tolerability of Co-artemether in Non-immune Travelers

NCT00233337 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Acute Uncomplicated P. Falciparum Malaria

Interventions

DRUG: Co-artemether

Sponsor

Novartis Pharmaceuticals